Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention

Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention

Abstract Introduction The efficacy of long-acting injectable cabotegravir (hereafter referred to as cabotegravir) versus daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (PrEP) was demonstrated in two phase 3 randomized controlled trials (RCTs), HPTN 083...

Full description

Saved in:
Bibliographic Details
Main Authors: Neil Hawkins, Paul O’Brien, Juliette Thompson, Sarah-Jane Anderson, Eric Manalastas, Laure Dupont-Benjamin, Melanie Schroeder
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-07-01
Series:Infectious Diseases and Therapy
Subjects:
Adherence
Cabotegravir
Effectiveness
Indirect treatment comparison
Long-acting injectable
Oral tenofovir disoproxil fumarate/emtricitabine
Online Access:https://doi.org/10.1007/s40121-025-01172-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items